RIT Assistant professor Stefan Schulze’s lab is working toward new biomedical treatment approaches through NIH research in proteomics.
Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, the companies said on Friday, gaining access to an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback